New England Discovery Partners (NEDP)

New England Discovery Partners (NEDP) is a Genesis Drug Discovery and Development (GD3) Company that specializes in medicinal chemistry, synthetic chemistry and X-ray crystallography. Established in 2012, NEDP is a contract research organization (CRO) comprised of experienced pharmaceutical scientists. They offer a diverse range of drug discovery services to academic investigators, pharmaceutical and biotechnology companies, emphasizing their dedication to “Making molecules that matter”. As a significant player in the Biotechnology sector, NEDP has the potential to attract interest from venture capital firms due to their expertise in a niche area of the industry. However, the lack of specific data on headquarters, recent investments, and investors leaves questions about the company’s current financial standing and growth trajectory. Investors seeking opportunities in the biotech industry may find NEDP an intriguing prospect, but further details and performance metrics are needed for a comprehensive evaluation.